Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection
Rev. Soc. Bras. Med. Trop
;
54(supl.1): e2020605, 2021. tab, graf
Article
in English
| LILACS
| ID: biblio-1250842
ABSTRACT
Abstract This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health. HTLV-1/2 infection is a public health problem globally, and Brazil has the largest number of individuals living with the virus. HTLV-1 causes several clinical manifestations of neoplasm (adult T-cell leukemia/lymphoma) and inflammatory nature, such as HTLV-1-associated myelopathy and other manifestations such as uveitis, arthritis, and infective dermatitis. These pathologies have high morbidity and mortality and negatively impact the quality of life of infected individuals. This review includes relevant information for health authorities professionals regarding viral transmission, diagnosis, treatment, and monitoring of individuals living with HTLV-1 and 2 in Brazil.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Human T-lymphotropic virus 1
/
HTLV-I Infections
/
Sexually Transmitted Diseases
Type of study:
Practice guideline
Limits:
Adult
/
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2021
Type:
Article
Affiliation country:
Brazil
/
United kingdom
Institution/Affiliation country:
Imperial College London/GB
/
Ministério da Saúde/BR
/
Universidade Federal da Bahia/BR
/
Universidade Federal do Pará/BR
/
Universidade de São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS